Piramal Pharma Share Price (PPLPHARMA)
as on
| Source : NSE
Piramal Pharma Stock Performance
as on August 14, 2025 at 4:01 PM IST
Day's Low
Day's High
₹189.55₹193.79
0.26%
Downside
1.97%
Upside
52 Week's Low
52 Week's High
₹181.5₹307.94.49%
Downside
62.02%
Upside
| Market Stats | |
| Previous Close | ₹192.13 |
| Open | ₹192.88 |
| Volume | 20.50L |
| Upper Circuit | ₹211.34 |
| Lower Circuit | ₹172.91 |
| Day's Low | ₹189.55 |
| Day's High | ₹193.79 |
| 52 Week Low | ₹181.5 |
| 52 Week High | ₹307.9 |
| Returns % | |
| 1 Month Return | -11.55 % |
| 3 Month Return | -7.24 % |
| 1 Year Return | + 4.37 % |
| 3 Year Return | + 0.02 % |
| 5 Year Return | + 0.02 % |
Piramal Pharma Stock Fundamentals & Key Indicators
Check Piramal Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹25,261.03 Cr
Return on Equity (ROE)
9.76
PE Ratio (TTM)
256.81
Return on capital employed (ROCE)
12.31
Industry PE ratio
43.28
Beta (LTM)
0.93
P/B Ratio
3.99
Dividend Yield
0.06
PEG Ratio
493.87
Quarterly Earnings Growth YOY
-7.83
EPS (TTM)
0.69
Sector
Pharmaceuticals
Book Value
61.35
Technical Analysis
Bearish
View Technical Analysis
Piramal Pharma Stock's Interest Amongst Investors
Piramal Pharma Stock Valuation
Track how Piramal Pharma P/E has moved over time to understand its valuation trends.
Piramal Pharma in the last 5 years
Lowest (-516.41x)
January 5, 2024
Industry (43.28x)
August 14, 2025
Today (256.81x)
August 14, 2025
Highest (2011.42x)
June 25, 2024
Today’s Price to Earnings Ratio: 256.81x
Piramal Pharma Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Piramal Pharma.
based on 9 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Piramal Pharma. Average target price of ₹256.67
Source: S&P Global Market Intelligence
Piramal Pharma Share Price Target
Get share price movements and forecasts by analysts on Piramal Pharma.
Piramal Pharma price forecast by 9 analysts
Upside of35.06%
High
₹305
Target
₹256.67
Low
₹230
Piramal Pharma target price ₹256.67, a slight upside of 35.06% compared to current price of ₹190.04. According to 9 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Piramal Pharma revenue growth forecast
Expected growth rate Q1, FY2027:23.38%
Forecast
Actual
Including amortisation and stock based compensations
Piramal Pharma EPS growth forecast
EPS estimate Q1, FY2027:537.68%
Forecast
Actual
Source: S&P Global Market Intelligence
Piramal Pharma Ltd Financial Results
Get the annual and quarterly financial summary of Piramal Pharma Ltd, including revenue, profit, loss and more.
Piramal Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Piramal Pharma.
Piramal Pharma Ltd Earnings Results
Piramal Pharma Ltd’s net profit jumped 7.83% since last year same period to ₹-81.70Cr in the Q1 2025-2026. On a quarterly growth basis, Piramal Pharma Ltd has generated -153.22% fall in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Pharma Ltd Dividends May,2025
In the quarter ending March 2025, Piramal Pharma Ltd has declared dividend of ₹0.14 per share on 14 May 2025 - translating a dividend yield of 0.07%.
Read More about Dividends
Indices Featuring Piramal Pharma Stock
Check stock indices that include Piramal Pharma.
Piramal Pharma Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Piramal Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 34.86% | ||
| Foreign Institutions | 12.91% | ||
| Mutual Funds | 12.32% | ||
| Retail Investors | 19.45% | 5.52 | |
| Others | 20.46% | 0.31 |
Piramal Pharma Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Piramal Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 25,261.03 | NA | 0.69 | 91 | 9,151 | |
| BUY | 34,960.90 | 32.7% | 0.52 | 300 | 1,051 | |
| BUY | 16,822.08 | 9.76% | 0.71 | 836 | 7,234 | |
| NA | 4,551.09 | -4.29% | 1.88 | -343 | 71 | |
| BUY | 15,765.90 | 48.97% | 0.67 | 244 | 1,515 |
Piramal Pharma News & Key Events
Latest news and events in one place to help you make informed investing decisions in Piramal Pharma.
Fire Incident Affects Piramal Pharma Inventory - 08 Aug, 2025
On August 6, a fire at a third-party warehouse in Telangana damaged Piramal Pharma's inventory worth Rs 45 crore. The fire is under control, and the cause is being investigated.Piramal Pharma Maintains Guidance Amid Q1 Weakness - 30 Jul, 2025
Piramal Pharma's Q1FY26 performance was weaker than expected, but management retains FY26 targets. Motilal Oswal recommends a Buy with a target price of Rs 240, citing anticipated recovery in the coming quarters.Piramal Pharma Reports Loss, Stock Declines Nearly 4% - 29 Jul, 2025
Piramal Pharma's Q1 FY26 results show a net loss of ₹82 crore, leading to a nearly 4% drop in stock price. Revenue declined 1% year-on-year, with CDMO business softness attributed to destocking. Despite challenges, the company aims for $2 billion revenue by FY30.Piramal Pharma Sells Decommissioned Thane Unit - 22 Jul, 2025
Piramal Pharma announced the sale of its decommissioned facility in Thane to Global Pharma for Rs 8.5 crore. The unit contributed nothing to revenue, ensuring no impact on ongoing operations.Piramal Pharma Dividend Announcement and Analyst Ratings - 15 Jul, 2025
Piramal Pharma announced a final dividend of ₹0.14 per share. Analysts maintain a buy rating with a target price of Rs 230, indicating a potential upside.
Insights on Piramal Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 18.44% to 19.45% in Jun 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 32.3% return, outperforming this stock by 28.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 153.5 Cr → -81.7 Cr (in ₹), with an average decrease of 153.2% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, PPLPHARMA stock has moved down by -11.6%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 13.49% to 12.91% in Jun 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.81K Cr → 2.03K Cr (in ₹), with an average decrease of 27.8% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 34.95% to 34.86% in Jun 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 12.73% to 12.32% in Jun 2025 quarter
About Piramal Pharma Ltd
Revenue: ₹1,933.71Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-81.70Cr as on June 2025 (Q1 FY26)
Listing date: 19 Oct, 2022
Chairperson Name: Nandini Piramal
| Organisation | Piramal Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Nandini Piramal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Piramal Pharma Stock
Check out the Mutual Funds with significant holdings in Piramal Pharma.
FAQs
What is Piramal Pharma share price today?
Piramal Pharma share price today stands at ₹190.04, Open: ₹192.88, Previous Close: ₹192.13, High: ₹193.79, Low: ₹189.55, 52 Week High: ₹307.9, 52 Week Low: ₹181.5 as on .
How to buy Piramal Pharma shares ?
To buy Piramal Pharma shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for PPLPHARMA or Piramal Pharma Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Piramal Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Piramal Pharma?
Today's traded volume of Piramal Pharma is 20.50L. Which means that 20.50L shares of Piramal Pharma were bought and sold on the stock market during today's trading session.
What is Piramal Pharma's market cap today?
Today's market capitalisation of Piramal Pharma is ₹25,261.03 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Piramal Pharma?
Piramal Pharma’s 52 week high is ₹307.9 and 52 week low is ₹181.5. The current share price of Piramal Pharma is ₹190.04, which is -38.28% down from its 52 week high and 4.71% up from its 52 week low.